[66] The attachment of OX40 and OX40L enhances the survival of CD4+ and CD8+ cells which increases tumor-specific responses of effector T cells in tumors and neutralizes the suppressive effects of Treg cells. The gene discussed is TNFRSF4; the disease is neoplasm.